Insider Selling: Evolent Health Inc (EVH) COO Sells 30,000 Shares of Stock

Share on StockTwits

Evolent Health Inc (NYSE:EVH) COO Thomas Peterson III sold 30,000 shares of Evolent Health stock in a transaction dated Thursday, August 30th. The stock was sold at an average price of $25.00, for a total transaction of $750,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Thomas Peterson III also recently made the following trade(s):

  • On Monday, July 2nd, Thomas Peterson III sold 10,000 shares of Evolent Health stock. The shares were sold at an average price of $21.21, for a total transaction of $212,100.00.

Shares of Evolent Health stock opened at $24.50 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.59 and a current ratio of 2.59. Evolent Health Inc has a 1 year low of $10.30 and a 1 year high of $25.82.

Evolent Health (NYSE:EVH) last announced its quarterly earnings results on Tuesday, August 7th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.01. The company had revenue of $144.51 million for the quarter, compared to analyst estimates of $141.90 million. Evolent Health had a negative net margin of 9.84% and a negative return on equity of 1.82%. analysts expect that Evolent Health Inc will post -0.34 earnings per share for the current fiscal year.

Several equities analysts have recently commented on the stock. TheStreet upgraded shares of Evolent Health from a “d+” rating to a “c-” rating in a research report on Monday, June 4th. ValuEngine upgraded shares of Evolent Health from a “hold” rating to a “buy” rating in a research report on Thursday, August 9th. Piper Jaffray Companies assumed coverage on shares of Evolent Health in a research report on Monday, June 4th. They issued an “overweight” rating and a $30.00 target price for the company. Zacks Investment Research upgraded shares of Evolent Health from a “hold” rating to a “buy” rating and set a $26.00 target price for the company in a research report on Tuesday, July 10th. Finally, MED boosted their target price on shares of Evolent Health from $22.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, June 18th. One equities research analyst has rated the stock with a sell rating and fourteen have given a buy rating to the company’s stock. Evolent Health currently has an average rating of “Buy” and a consensus price target of $26.92.

Several institutional investors have recently made changes to their positions in the stock. Schroder Investment Management Group grew its holdings in shares of Evolent Health by 40.2% during the 2nd quarter. Schroder Investment Management Group now owns 76,426 shares of the technology company’s stock valued at $1,674,000 after purchasing an additional 21,925 shares during the last quarter. Waddell & Reed Financial Inc. grew its holdings in shares of Evolent Health by 0.7% during the 2nd quarter. Waddell & Reed Financial Inc. now owns 1,173,174 shares of the technology company’s stock valued at $24,695,000 after purchasing an additional 7,687 shares during the last quarter. MetLife Investment Advisors LLC grew its holdings in shares of Evolent Health by 24.8% during the 2nd quarter. MetLife Investment Advisors LLC now owns 31,066 shares of the technology company’s stock valued at $654,000 after purchasing an additional 6,178 shares during the last quarter. Metropolitan Life Insurance Co. NY grew its holdings in shares of Evolent Health by 12.6% during the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 22,031 shares of the technology company’s stock valued at $464,000 after purchasing an additional 2,459 shares during the last quarter. Finally, Tower Research Capital LLC TRC bought a new stake in shares of Evolent Health during the 2nd quarter valued at approximately $369,000.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Further Reading: How to Invest in Marijuana Stocks

Insider Buying and Selling by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply